documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
508 rows where docket_id = "FDA-1995-N-0054" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 4
- Supporting & Related Material 494
- Notice 8
- Other 3
- Rule 3
agency_id 1
- FDA 508
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-N-0054-13947 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Guidance -GDL | Other | GDL-Guidance (Supporting and Related Materials) | 2008-07-17T04:00:00Z | 2008 | 7 | 2008-07-17T04:00:00Z | 2008-07-17T13:14:51Z | 0 | 0 | 090000648067fea6 | ||
| FDA-1995-N-0054-13946 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Small Entity Compliance Guide: Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Availability | Notice | NAD-Notice of Availability of Data | 2008-07-17T04:00:00Z | 2008 | 7 | 2008-07-17T04:00:00Z | 2016-06-03T13:00:26Z | E8-16396 | 0 | 0 | 090000648067faba | |
| FDA-1995-N-0054-13945 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | HFA-305 to American Herbal Products Assnociation | Other | ACK-Acknowledgement Letter | 2004-08-20T04:00:00Z | 2004 | 8 | 2008-05-16T22:31:18Z | 0 | 0 | 090000648056b99b | |||
| FDA-1995-N-0054-13900 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | HFA-305 to Kleinfeld, Kaplan and Becker | Other | ACK-Acknowledgement Letter | 2004-03-12T05:00:00Z | 2004 | 3 | 2008-05-16T22:30:30Z | 0 | 0 | 090000648056b86e | |||
| FDA-1995-N-0054-13487 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:36Z | 0 | 0 | 090000648056b442 | |||
| FDA-1995-N-0054-13528 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:57Z | 0 | 0 | 090000648056b46f | |||
| FDA-1995-N-0054-13813 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:17Z | 0 | 0 | 090000648056b6c4 | |||
| FDA-1995-N-0054-13826 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b6e1 | |||
| FDA-1995-N-0054-13694 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:45Z | 0 | 0 | 090000648056b5d2 | |||
| FDA-1995-N-0054-13687 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:20Z | 0 | 0 | 090000648056b5bf | |||
| FDA-1995-N-0054-13711 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:13Z | 0 | 0 | 090000648056b5fb | |||
| FDA-1995-N-0054-13690 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:03Z | 0 | 0 | 090000648056b5c9 | |||
| FDA-1995-N-0054-13457 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:43Z | 0 | 0 | 090000648056b423 | |||
| FDA-1995-N-0054-13463 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:39Z | 0 | 0 | 090000648056b429 | |||
| FDA-1995-N-0054-13453 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:30:35Z | 0 | 0 | 090000648056b41e | |||
| FDA-1995-N-0054-13678 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:02Z | 0 | 0 | 090000648056b5a7 | |||
| FDA-1995-N-0054-13647 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:30:34Z | 0 | 0 | 090000648056b537 | |||
| FDA-1995-N-0054-13685 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:43Z | 0 | 0 | 090000648056b5bb | |||
| FDA-1995-N-0054-13659 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:42Z | 0 | 0 | 090000648056b555 | |||
| FDA-1995-N-0054-13649 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:19Z | 0 | 0 | 090000648056b53c | |||
| FDA-1995-N-0054-13609 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b4f9 | |||
| FDA-1995-N-0054-13607 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:52Z | 0 | 0 | 090000648056b4f5 | |||
| FDA-1995-N-0054-13566 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:59Z | 0 | 0 | 090000648056b498 | |||
| FDA-1995-N-0054-13561 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:38Z | 0 | 0 | 090000648056b493 | |||
| FDA-1995-N-0054-13549 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:26Z | 0 | 0 | 090000648056b487 | |||
| FDA-1995-N-0054-13539 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:42Z | 0 | 0 | 090000648056b47a | |||
| FDA-1995-N-0054-13462 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:30:28Z | 0 | 0 | 090000648056b428 | |||
| FDA-1995-N-0054-13479 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:13Z | 0 | 0 | 090000648056b43a | |||
| FDA-1995-N-0054-13475 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:56Z | 0 | 0 | 090000648056b436 | |||
| FDA-1995-N-0054-13497 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:24Z | 0 | 0 | 090000648056b44c | |||
| FDA-1995-N-0054-13488 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:13Z | 0 | 0 | 090000648056b443 | |||
| FDA-1995-N-0054-13525 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:48Z | 0 | 0 | 090000648056b46c | |||
| FDA-1995-N-0054-13786 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:26Z | 0 | 0 | 090000648056b694 | |||
| FDA-1995-N-0054-13776 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:15Z | 0 | 0 | 090000648056b67b | |||
| FDA-1995-N-0054-13779 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:49Z | 0 | 0 | 090000648056b683 | |||
| FDA-1995-N-0054-13773 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:15Z | 0 | 0 | 090000648056b675 | |||
| FDA-1995-N-0054-13763 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:15Z | 0 | 0 | 090000648056b65a | |||
| FDA-1995-N-0054-13810 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:39Z | 0 | 0 | 090000648056b6be | |||
| FDA-1995-N-0054-13806 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:30:31Z | 0 | 0 | 090000648056b6b2 | |||
| FDA-1995-N-0054-13818 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:27Z | 0 | 0 | 090000648056b6d0 | |||
| FDA-1995-N-0054-13720 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:40Z | 0 | 0 | 090000648056b612 | |||
| FDA-1995-N-0054-13716 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:46Z | 0 | 0 | 090000648056b608 | |||
| FDA-1995-N-0054-13715 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:21Z | 0 | 0 | 090000648056b605 | |||
| FDA-1995-N-0054-13689 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:03Z | 0 | 0 | 090000648056b5c6 | |||
| FDA-1995-N-0054-13868 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:41Z | 0 | 0 | 090000648056b72a | |||
| FDA-1995-N-0054-13870 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:29Z | 0 | 0 | 090000648056b72c | |||
| FDA-1995-N-0054-13874 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:18Z | 0 | 0 | 090000648056b732 | |||
| FDA-1995-N-0054-13861 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:53Z | 0 | 0 | 090000648056b723 | |||
| FDA-1995-N-0054-13867 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:28Z | 0 | 0 | 090000648056b729 | |||
| FDA-1995-N-0054-13852 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b718 | |||
| FDA-1995-N-0054-13880 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:26Z | 0 | 0 | 090000648056b73e | |||
| FDA-1995-N-0054-13897 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:46Z | 0 | 0 | 090000648056b763 | |||
| FDA-1995-N-0054-13594 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:51Z | 0 | 0 | 090000648056b4d1 | |||
| FDA-1995-N-0054-13610 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b4fb | |||
| FDA-1995-N-0054-13604 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b4ef | |||
| FDA-1995-N-0054-13597 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:44Z | 0 | 0 | 090000648056b4dd | |||
| FDA-1995-N-0054-13674 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:46Z | 0 | 0 | 090000648056b58b | |||
| FDA-1995-N-0054-13668 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:54Z | 0 | 0 | 090000648056b57e | |||
| FDA-1995-N-0054-13684 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:47Z | 0 | 0 | 090000648056b5b7 | |||
| FDA-1995-N-0054-13573 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:50Z | 0 | 0 | 090000648056b4a1 | |||
| FDA-1995-N-0054-13516 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:15Z | 0 | 0 | 090000648056b463 | |||
| FDA-1995-N-0054-13509 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:57Z | 0 | 0 | 090000648056b459 | |||
| FDA-1995-N-0054-13896 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:42Z | 0 | 0 | 090000648056b762 | |||
| FDA-1995-N-0054-13889 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:02Z | 0 | 0 | 090000648056b757 | |||
| FDA-1995-N-0054-13846 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b708 | |||
| FDA-1995-N-0054-13767 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:58Z | 0 | 0 | 090000648056b663 | |||
| FDA-1995-N-0054-13782 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:26Z | 0 | 0 | 090000648056b68a | |||
| FDA-1995-N-0054-13783 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:58Z | 0 | 0 | 090000648056b68c | |||
| FDA-1995-N-0054-13785 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:26Z | 0 | 0 | 090000648056b692 | |||
| FDA-1995-N-0054-13764 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:22Z | 0 | 0 | 090000648056b65c | |||
| FDA-1995-N-0054-13655 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:26Z | 0 | 0 | 090000648056b54b | |||
| FDA-1995-N-0054-13606 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b4f3 | |||
| FDA-1995-N-0054-13623 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:30:33Z | 0 | 0 | 090000648056b50c | |||
| FDA-1995-N-0054-13627 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b510 | |||
| FDA-1995-N-0054-13842 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:44Z | 0 | 0 | 090000648056b703 | |||
| FDA-1995-N-0054-13843 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:52Z | 0 | 0 | 090000648056b704 | |||
| FDA-1995-N-0054-13851 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:52Z | 0 | 0 | 090000648056b716 | |||
| FDA-1995-N-0054-13879 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:18Z | 0 | 0 | 090000648056b73c | |||
| FDA-1995-N-0054-13754 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:30:30Z | 0 | 0 | 090000648056b644 | |||
| FDA-1995-N-0054-13755 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:41Z | 0 | 0 | 090000648056b647 | |||
| FDA-1995-N-0054-13769 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:42Z | 0 | 0 | 090000648056b66d | |||
| FDA-1995-N-0054-13775 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:58Z | 0 | 0 | 090000648056b679 | |||
| FDA-1995-N-0054-13748 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:24Z | 0 | 0 | 090000648056b639 | |||
| FDA-1995-N-0054-13765 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:25Z | 0 | 0 | 090000648056b65f | |||
| FDA-1995-N-0054-13653 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:29Z | 0 | 0 | 090000648056b546 | |||
| FDA-1995-N-0054-13675 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:29Z | 0 | 0 | 090000648056b5a1 | |||
| FDA-1995-N-0054-13680 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:47Z | 0 | 0 | 090000648056b5ae | |||
| FDA-1995-N-0054-13683 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:20Z | 0 | 0 | 090000648056b5b4 | |||
| FDA-1995-N-0054-13650 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:32:02Z | 0 | 0 | 090000648056b53e | |||
| FDA-1995-N-0054-13681 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:27Z | 0 | 0 | 090000648056b5b0 | |||
| FDA-1995-N-0054-13682 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:33:30Z | 0 | 0 | 090000648056b5b2 | |||
| FDA-1995-N-0054-13615 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:52Z | 0 | 0 | 090000648056b504 | |||
| FDA-1995-N-0054-13588 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:51Z | 0 | 0 | 090000648056b4c4 | |||
| FDA-1995-N-0054-13593 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:17Z | 0 | 0 | 090000648056b4cf | |||
| FDA-1995-N-0054-13570 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:50Z | 0 | 0 | 090000648056b49e | |||
| FDA-1995-N-0054-13568 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:59Z | 0 | 0 | 090000648056b49b | |||
| FDA-1995-N-0054-13578 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:31:16Z | 0 | 0 | 090000648056b4ac | |||
| FDA-1995-N-0054-13565 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:27:50Z | 0 | 0 | 090000648056b497 | |||
| FDA-1995-N-0054-13580 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:28:39Z | 0 | 0 | 090000648056b4b0 | |||
| FDA-1995-N-0054-13542 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Material for NFR 1 | Supporting & Related Material | BKG-Background Material | 2004-02-06T05:00:00Z | 2004 | 2 | 2008-05-16T22:29:23Z | 0 | 0 | 090000648056b47d |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;